What is NDC 0115-1070?

0115-1070 is the product NDC for Dipyridamole, Dipyridamole 25 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals of New York LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals of New York LLC, NDC labeler code 0115. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dipyridamole?

15 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dipyridamole NDC 0115-1070 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0115-1070Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00115-1070Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0115-1070-01	00115107001	100 TABLET in 1 BOTTLE (0115-1070-01)Marketed from Aug 30, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dipyridamole
Generic name (nonproprietary): dipyridamole
Active ingredients: Dipyridamole — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals of New York LLCNDC labeler code 0115
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040782
Marketing start: Aug 30, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Platelet Aggregation (Physiologic effect)
Identifiers: Product ID 0115-1070_02250a0f-40e1-4f73-8ead-1be26f78edc8SPL ID 02250a0f-40e1-4f73-8ead-1be26f78edc8SPL set ID a18b2af5-7c4a-4b7f-92c7-8a76e34da373RxCUI 197622, 309952, 309955UNII 64ALC7F90CUPC 0301151072015, 0301151071018, 0301151070011
Pharmacologic class: Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400115107001 followed by a unit qualifier and the quantity

Package 00115-1070-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0115-1070

What is NDC 0115-1070?: 0115-1070 is the product NDC for Dipyridamole, Dipyridamole 25 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals of New York LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dipyridamole.
What is the active ingredient?: Dipyridamole.
Who is the labeler?: Amneal Pharmaceuticals of New York LLC, NDC labeler code 0115. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dipyridamole?: 15 other product NDCs are listed under this name. See all Dipyridamole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dipyridamole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4650	70518-4650-00
Dipyridamole	Dipyridamole 5 mg/mL	InjectionIntravenous	Henry Schein, Inc.	0404-9852	00404-9852-10
Dipyridamole	Dipyridamole 50 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-1071	00115-1071-01
Dipyridamole	Dipyridamole 75 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-1072	00115-1072-01
Dipyridamole	Dipyridamole 25 mg/1	Tablet, Film coatedOral	Oxford Pharmaceuticals, LLC	69584-181	69584-0181-10
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	Oxford Pharmaceuticals, LLC	69584-182	69584-0182-10
Dipyridamole	Dipyridamole 75 mg/1	Tablet, Film coatedOral	Oxford Pharmaceuticals, LLC	69584-183	69584-0183-10
Dipyridamole	Dipyridamole 5 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1447	51662-1447-01
Dipyridamole	Dipyridamole 25 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	68382-187	68382-0187-0168382-0187-0568382-0187-10+1 more
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	68382-188	68382-0188-0168382-0188-0568382-0188-10+1 more

All 16 Dipyridamole NDCs

Other NDCs under ANDA 040782

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040782
Product	Strength	Form · route	Labeler	Product NDC
Dipyridamole	Dipyridamole 50 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-1071
Dipyridamole	Dipyridamole 75 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	0115-1072